C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/18/2001	CA2401290A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	CA2343602A1 Est's and encoded human proteins
10/17/2001	EP1146339A2 Methods for judging resistance to the onset of bovine leukemia
10/17/2001	EP1146125A1 Poxvirus with targeted infection specificity
10/17/2001	EP1146124A2 Gustducin materials and methods
10/17/2001	EP1146123A1 Megsin promoter
10/17/2001	EP1146122A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor)
10/17/2001	EP1146121A1 Method for modification of proteins by transglutaminase
10/17/2001	EP1146120A1 Method for obtaining specific T-lymphocites, and for identifying etitopes
10/17/2001	EP1146056A1 Antibodies which activate an erythropoietin receptor
10/17/2001	EP1146055A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor)
10/17/2001	EP1146054A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
10/17/2001	EP1146053A1 Meg-4 protein
10/17/2001	EP1146052A2 Arthropod defensins
10/17/2001	EP1145721A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor)
10/17/2001	EP1145644A2 Glycoprotein having inhibitory activity against helicobacter pylori colonization
10/17/2001	EP1145013A2 Removal of prions from blood, plasma and other liquids
10/17/2001	EP1145011A2 Compositions and methods for the diagnosis and treatment of tumor
10/17/2001	EP1144998A2 Neisseria genomic sequences and methods of their use
10/17/2001	EP1144997A2 Methods and compounds for modulating nuclear receptor activity
10/17/2001	EP1144687A2 Method for the affinity isolation of newly synthesized rna
10/17/2001	EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001	EP1144678A2 Susceptibility to psoriasis
10/17/2001	EP1144666A2 Replication deficient baculovirus expression system
10/17/2001	EP1144662A1 Methods and means for modification of plant characteristics using the vernalization gene vrn2
10/17/2001	EP1144661A2 Method of genetic modification of a wild type viral sequence
10/17/2001	EP1144659A2 Trans-acting factors in yeast
10/17/2001	EP1144655A2 Regulated expression using conditional er retention domains
10/17/2001	EP1144650A2 Goodpasture antigen binding protein
10/17/2001	EP1144646A2 Mutant hepatitis b surface antigen and testing
10/17/2001	EP1144645A1 Neisseria meningitidis polypeptide basb052
10/17/2001	EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001	EP1144643A1 Neisseria meningitidis antigen
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144641A2 Serotype-specific probes for listeria monocytogenes
10/17/2001	EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	EP1144639A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/17/2001	EP1144638A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/17/2001	EP1144637A2 Wuschel (wus) gene homologs
10/17/2001	EP1144636A2 Human genes and gene expression products
10/17/2001	EP1144635A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144633A1 Polypeptide
10/17/2001	EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001	EP1144631A2 Insulin-synthesis genes
10/17/2001	EP1144630A2 Human cell signaling proteins (csig)
10/17/2001	EP1144629A2 Further pro polypeptides and sequences thereof
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144627A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b
10/17/2001	EP1144625A2 Nucleic-acid binding proteins
10/17/2001	EP1144624A2 Human and mouse trek-1 potassium channel protein and their use
10/17/2001	EP1144622A2 Polynucleotides and their application in diagnostics
10/17/2001	EP1144618A1 Method for isolating apoptosis-inducing dna sequences and detection system
10/17/2001	EP1144617A2 Cancer-associated proteins
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144613A1 Methods for making proteins containing free cysteine residues
10/17/2001	EP1144611A2 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin
10/17/2001	EP1144607A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
10/17/2001	EP1144606A2 Human nucleic acid and protein sequences obtained from endothelial cells
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144593A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling
10/17/2001	EP1144590A1 Compartmentalization of recombinant polypeptides in host cells
10/17/2001	EP1144454A2 Modified peptides as therapeutic agents
10/17/2001	EP1144451A2 Method of modulating cell differentiation or neoplastic trnasformation by altering cadherin-11 expression or function
10/17/2001	EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001	EP1144449A1 Reagents and methods useful for detecting diseases of the breast
10/17/2001	EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
10/17/2001	EP1144447A2 Tuberculosis diagnostic test
10/17/2001	EP1144446A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease
10/17/2001	EP1144444A2 Dnas encoding proteins with signal sequences
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144442A2 Streptococcal alpha2m-binding protein
10/17/2001	EP1144440A2 Neurotransmitter transporter
10/17/2001	EP1144439A2 Hematopoietic regulatory factors and methods of use thereof
10/17/2001	EP1144438A2 Polypeptides having acid phosphatase activity and nucleic acids encoding same
10/17/2001	EP1144437A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use
10/17/2001	EP1144005A1 Treatment of papillomavirus infections
10/17/2001	EP1144004A1 Her-2 binding antagonists
10/17/2001	EP1143999A2 Lipoprotein complexes and compositions containing them
10/17/2001	EP1143997A1 Tumor necrosis factor antagonists and their use in endometriosis
10/17/2001	EP1143996A2 Method of treating chronic cardiac disease
10/17/2001	EP1143995A1 Anti-dandruff composition comprising an antifungal polypeptide
10/17/2001	EP1143800A1 Biological control of nematodes
10/17/2001	EP0871662B1 Product derived from milk substantially free of beta casein from non-human mammals and relative use
10/17/2001	EP0792367B1 A dna construct encoding the yap3 signal peptide
10/17/2001	EP0692025B1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
10/17/2001	EP0489149B1 Probes for detecting mutant p53
10/17/2001	CN1318105A Methods for down-regulating osteoprotegerin ligand activity
10/17/2001	CN1318104A HIV vaccine
10/17/2001	CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	CN1318102A OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use
10/17/2001	CN1318101A New human growth differentiation factor encoding sequence and polypeptide encoded by such DNA sequence and producing method thereof
10/17/2001	CN1318100A New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such DNA sequence and producing method thereof
10/17/2001	CN1318099A LY6H gene
10/17/2001	CN1318070A Modified i(E.coli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein
10/17/2001	CN1318068A Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
10/17/2001	CN1317976A Multicomponent vaccines
10/17/2001	CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1073159C Human kunitz-type protease inhibitors and its related method

1 ... 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 ... 2916